pegunigalsidase alfa

CHEBI:CHEBI_755485

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2676760
generic_name
pegunigalsidase alfa
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
marketing_start_date
20230523
package_marketing_start_date
20240708
route
INTRAVENOUS
dosage_form
INJECTION, SOLUTION, CONCENTRATE
marketing_category
BLA
active_ingredient_strength
5 mg/2.5mL
labeler_name
Chiesi USA, Inc.
manufacturer_name
Chiesi USA, Inc.
pharm_class_cs
alpha-Glucosidases [CS]
nui
N0000175822
pharm_class_epc
Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]
brand_name
ELFABRIO
brand_name_base
ELFABRIO
product_ndc
10122-165
application_number
BLA761161
spl_id
ca12aa63-7344-4996-bfb4-d2289c245f4a
active_ingredient_name
PEGUNIGALSIDASE ALFA
package_ndc
10122-165-02
package_description
1 VIAL, SINGLE-DOSE in 1 CARTON (10122-165-02) / 2.5 mL in 1 VIAL, SINGLE-DOSE
unii
8M7V7Q6537
spl_set_id
6fb674bf-744e-431f-92ef-b2a5a66c8cf3
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class